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Abstract
Background: Current research suggests that protein intake of 1.5 – 2.8 g/kg/day (3.5 times the
current recommended daily allowance) is effective and safe for individuals trying to increase or
maintain lean muscle mass. To achieve these levels of daily protein consumption, supplementing the
diet with processed whey protein concentrate (WPC) in liquid form has become a popular choice
for many people. Some products have a suggested serving size as high as 50 g of protein. However,
due to possible inhibition of endogenous digestive enzymes from over-processing and rapid small
intestine transit time, the average amount of liquid WPC that is absorbed may be only 15 g. The
combined effect of these factors may contribute to incomplete digestion, thereby limiting the
absorption rate of protein before it reaches the ceacum and is eliminated as waste. The purpose
of this study was to determine if Aminogen®, a patented blend of digestive proteases from
Aspergillus niger and Aspergillus oryzae, would significantly increase the in-vivo absorption rate of
processed WPC over control values. It also investigated if any increase would be sufficient to
significantly alter nitrogen (N2) balance and C-reactive protein (CRP) levels over control values as
further evidence of increased WPC absorption rate.
Methods: Two groups of healthy male subjects were assigned a specified balanced diet before and
after each of two legs of the study. Subjects served as their own controls. In the first leg each
control group (CG) was dosed with 50 g of WPC following an overnight fast. Nine days later each
test group (TG) was dosed following an overnight fast with 50 g of WPC containing either 2.5 g
(A2.5) or 5 g (A5) of Aminogen®. Blood samples were collected during each leg at 0 hr, 0.5 hr, 1
hr, 2 hr, 3 hr, 3.5 hr and 4 hr for amino acid (AA) and CRP analyses. The following 18 AAs were
quantified: alanine, arginine, aspartic acid, cysteine, glutamic acid, glycine, histidine, isoleucine,
leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine and
valine. Urine was collected for 24 hours from 0 hr for total N2 analysis. Results are expressed as
means ± SEM. All significance and power testing on results was done at a level of alpha = 0.05. Area
under the concentration time curve (AUC) was calculated using the trapezoidal rule. One-way
analysis of variance (ANOVA-1) was done between CGs, between TGs and between time points.
One-way repeated measures analysis of variance (ANOVA-1-RM) was done to compare CGs and
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TGs. Two-way analysis of variance (ANOVA-2) was performed on total serum amino acid (TSAA)
levels, urine N2 levels and CRP levels between each CG and TG.
Results: After baseline subtraction the mean AUC was significantly (p ≤ 0.05) greater in each TG
compared the corresponding CG. Comparison of the mean AUC between each TG and each CG
was not significantly different. Total serum amino acid (TSAA) levels were significantly greater in
each TG compared the corresponding CG. They were also significantly different between each TG
but not between each CG. All individual serum amino acid (ISAA) levels in TG-A2.5 except glycine,
histidine, methionine and serine were significantly higher than in CG-A2.5 at 4 hr. All ISAA levels
in TG-A5 except methionine and serine were significantly higher than in CG-A5 at 4 hr. The N2
balance was significantly higher in each TG compared to the corresponding CG, but not significantly
different between each CG and between each TG. Significant differences in CRP levels are reported
between each TG compared to the corresponding CG, but not significantly different between each
TG and between each CG.
Conclusion: A patented blend of digestive proteases (Aminogen®) increased the absorption rate
of processed WPC over controls, as measured by statistically significant increases in AUC, TSAA
levels, ISAA levels and N2 balance. Significant decreases in CRP levels and fluxes in AA levels are
also reported.
Background
Increased protein consumption has become increasingly
popular among individuals, especially athletes, trying to
increase or maintain lean muscle mass. Whey protein con-
centrate (WPC) in liquid form has become a popular pro-
tein supplement because it has been characterized as
rapidly and easily digestible. Clinical studies have
reported that approximately 30 g of WP as a liquid meal
produced a large but transient rise in postprandial plasma
AA levels in approximately 90 minutes and returned to
baseline within 5 hours. The rise in AA levels increased
protein synthesis and nitrogen (N2) balance but did not
inhibit whole body protein breakdown [1,2]. Recently, it
has been reported that the intake of WP above 1.5 g/kg/
day helped decrease body fat, increase lean body mass and
maintain nitrogen (N2) balance [3]. Protein intake as
high as 2.8 g/kg/day (3.5 times the current recommended
daily allowance) was reported to have no adverse effects
on renal function [4]. To help achieve these high levels of
protein intake, some WPC products have a suggested serv-
ing size of 50 g. However, several factors could limit pro-
tein digestion and absorption at this level of
consumption. Digestion may be compromised by indus-
trial-scale WPC production techniques, such as spray-dry-
ing and pressurized microfiltration, which have been
reported to inhibit the activity of digestive enzymes in-
vitro due to over-processing [5]. The addition of proteo-
lytic enzymes to WPC solutions has been reported to
increase the degree of hydrolysis (DH), solubility and
concomitant in-vitro digestibility (IVD) [6]. Absorption
may be compromised by the rapid transit time through
the small intestine to the ceacum, which has been
reported to be an average of 1.5 hours for viscous liquids
[7]. The maximum absorption rate of WP has been
reported to be 8 to 10 g/hr [8]. Using these parameters, the
maximum amount of WP that could be absorbed from a
liquid is 15 g. The combined effects of over-processing
and increased intake may contribute to incomplete WPC
digestion. This could reduce some of the positive thera-
peutic effects of a high protein diet including increased
lean muscle mass, increased N2 retention and positive
cardiovascular effects such as reduced levels of C-reactive
protein (CRP) [9-11]. Increasing the amount of WPC
digested, before it reaches the ceacum, may increase the
absorption rate and the desired outcome of a high protein
diet.
Therefore, we hypothesize that the addition of digestive
proteases would increase the absorption rate of WPC in-
vivo, produce a positive N2 balance and decrease CRP lev-
els. Changes in WPC absorption rate and CRP levels are
determined by comparing levels of total amino acids
(TSAA), individual amino acids (IAA) and CRP levels in
the serum of a control group (CG) to serum levels in a test
group (TG). Differences in N2 balance are determined by
comparing the total urine N2 excreted in a CG to total
urine N2 excreted in a TG.
Methods
Experimental design
Two groups of healthy, male subjects were dosed with 50
g of WPC as CGs and nine days later with 50 g of WPC
containing either 2.5 g or 5 g of a patented proteolytic
enzyme formula from food grade Aspergillus niger and
Aspergillus oryzae as TGs (Aminogen®, Triarco Industries,
Wayne, NJ). Serum levels of postprandial amino acids
(AAs) were used to monitor differences in WPC absorp-Journal of the International Society of Sports Nutrition 2008, 5:10 http://www.jissn.com/content/5/1/10
Page 3 of 8
(page number not for citation purposes)
tion rate and urine levels of urea were used to determine
total N2 [12].
Whey protein concentrate
The protein used in this study was dry WPC, 85% protein
on a dry basis, 6% fat, 3% ash and 6% lactose (Alacen
131, NZP North America). It was recovered from cheese
production, processed by membrane separation and
spray-dried. Natural vanilla (0.2%) (Craftmaster) was
added for flavor. No solubilizers, emulsifiers or other
excipients were added. Control and test samples were sup-
plied in pre-measured individual dose packets of 50 g
each (42.5 g protein). Control WPC contained no proteo-
lytic enzymes and the test WPC was blended with either
2.5 or 5 g of Aminogen®, (US patent # 5,387,422).
Subjects
Two groups of twenty-one healthy, lean, males ages 19–
35, each with a body mass index (BMI) ranging from 20
to 24, volunteered for this study. None of the participants
were following any particular protein-rich dietary regime,
muscle-toning or bodybuilding program during the study.
The study was approved and performed in accordance
with the University of Yaounde I, Cameroon Institutional
Review Board (IRB). Each participant was informed of the
purpose, methods, and possible risks associated with the
study, and informed consent was obtained from each par-
ticipant. All but one participant completed the study and
was not included in any statistical analyses.
Dietary protocol
Participants followed a specified, balanced diet of 2200
Kcal/day during a one week standardization period prior
to the start of the study and for nine days between each leg
of the study. An overnight fast was required before Day 1
and Day 2 of testing. Participants resumed the diet after
the last blood draw on Day 1. Nutrient composition con-
sisted of 40% carbohydrate, 25% protein and 35% fat.
The precise weight and composition was established for
each individual by a registered dietician at the University
of Yaounde Teaching Hospital (CHU). Participants
received a main meal of the day at the Laboratory of Nutri-
tion and Nutritional Biochemistry, University of Yaounde
1, and given precise take-out portions for their other
meals. Participants were advised to strictly follow their
prescribed diets during the study period.
Control group
Before the study, all participants (n = 41) followed the
standardized diet in the dietary protocol for one week and
then reported to the Laboratory of Nutrition and Nutri-
tional Biochemistry after an overnight fast for Day 1 of the
study. On Day 1, control samples were collected after all
participants ingested one 50 g, pre-measured packet of
WPC (42.5 g protein) without Aminogen®. The entire con-
tents of each individual serving packet were emptied into
0.5 L of distilled water, vigorously shaken and consumed.
Blood samples were collected at 0 hr (baseline, immedi-
ately prior to ingestion) 0.5 hr, 1 hr, 2 hr, 3 hr, 3.5 hr and
4 hr to measure TSAA, IAA and CRP levels. Urine was col-
lected over 24 hours from each participant at the start of
fasting and pooled to measure total N2 excretion. N2
excretion from sweat and feces was not measured. The
CGs were designated as CG-A2.5 (n = 21) and CG-A5 (n =
20).
Test groups
Following a second standardization period of nine days
and an over-night fast, the participants returned to the
Laboratory of Nutrition and Nutritional Biochemistry for
Day 2 of the study. Each participant was randomly
assigned to one of two TGs, receiving either 2.5 g Amino-
gen®, pre-blended in 50 g WPC (n = 21) or 5 g of Amino-
gen®, pre-blended in 50 g WPC (n = 20) designated as TG-
A2.5 and TG-A5. The entire contents of each individual
serving packet containing Aminogen® were emptied into
0.5 L of distilled water, vigorously shaken and consumed.
Test data was determined from blood and urine. Blood
samples were collected at 0 hr (baseline, immediately
prior to ingestion) 0.5 hr, 1 hr, 2 hr, 3 hr, 3.5 hr and 4 hr
to measure TSAA, IAA and CRP levels. Urine was collected
over 24 hours and pooled to measure total nitrogen excre-
tion. N2 excretion from sweat and feces was not meas-
ured. Following the study, the control data from each
participant was compared to the data from the corre-
sponding patient in either of the two test groups.
Sample collection
Whole blood samples (approximately 5 mL) were col-
lected by a phlebotomist from either an affixed catheter or
multiple venous punctures, and transferred to plain Vacu-
tainer® tubes. Serum was prepared by centrifugation and
stored in 200 μl aliquots at -20°C until needed for analy-
ses. Prior to each blood draw at 0 hr, 2 hr and 4 hr, heart
rate (HR) and blood pressure (BP) were recorded by an
attending technician. Pooled urine from each patient in
each CG and TG was collected and refrigerated until ana-
lyzed for nitrogen.
Analytical analyses
All serum and urine samples were submitted to the labo-
ratory blinded to remove any analytical bias.
Amino acid (AA) analyses consisted of quantification of
eighteen individual serum amino acids for each patient at
each time point. Analyses were performed on a Beckman
6300 AA analyzer using ion exchange chromatography
and a post column derivatazation with ninhydrin and UV
detection. Quantification was done versus reference
standard mixtures and control mixtures of known quanti-Journal of the International Society of Sports Nutrition 2008, 5:10 http://www.jissn.com/content/5/1/10
Page 4 of 8
(page number not for citation purposes)
ties of all eighteen AA (Sigma, St. Louis, MO). Within run
variations in control values of greater than +/- 20%
required reanalysis. AA levels are reported in mg/L and as
percent AUC. TSAA levels were reported as the total sum
of all eighteen AAs. The percent AUC was reported as the
amount each AA contributed to the total. Urinary nitrogen
was determined manually by the AOAC Kjeldahl diges-
tion flask method [13]. Within run variations in control
values of greater than +/- 20% required reanalysis. CRP
was measured by a highly sensitive immunoturbidimetric
assay (Dade Behring, Paris France) by forming an
immune complex with specific antibodies. Within run
variations in control values of greater than +/- 20%
required reanalysis.
Statistical analyses
All significance and power testing on results was done at a
level of alpha = 0.05. Within group analyses was done
between each corresponding CG and TG and between
group analyses was done between both CGs and between
both TGs. The mean area under the concentration time
curve (AUC) was calculated after baseline subtraction
using the trapezoidal rule. One-way repeated measures
analysis of variance (ANOVA-1-RM) was performed on
mean AUC between each corresponding CG and TG. One-
way analysis of variance (ANOVA-1) was performed on
mean AUC between both CGs and between both TGs.
Two-way analysis of variance (ANOVA-2) was performed
on TSAA levels between each corresponding CG and TG.
ANOVA-1 was performed on TSAA levels between 0 hr
and each time point within each CG and TG and on area
percents of each IAA level at 0 hr and 4 hr. ANOVA-2 was
used on the urine N2 and CRP levels between each corre-
sponding CG and TG. Results are expressed as means ±
SEM. Statistics were performed using a commercially
available software program (Origin® for Windows, version
8.0).
Results
Average TSAA levels and AUC
After baseline subtraction, the AUC of TG-A2.5 was 2.2
times greater than the corresponding CG-A2.5 and the
AUC of TG-A5 was 3.5 times greater than the correspond-
ing CG-A5. The mean area differences were significantly
greater in each TG compared to the corresponding CG (p
= 0.04). Mean area differences between both TGs and
both CGs were not significantly different.
Analysis of TSAA kinetic profiles of all groups showed a
progressive, time-dependant increase through 4 hr.
ANOVA-2 comparison of means between CG-A2.5 and
the corresponding TG-A2.5 showed differences between
groups and all time points to be significant (p = 0.05). The
interaction between time points and dose groups was also
significant (p = 0.05). A statistical power of 1.0 was
reached between all comparisons. Comparison of means
between CG-A5 and the corresponding TG-A5 showed
differences between groups and all time points to be sig-
nificant (p = 0.05). The interaction between time points
and dose groups was also significant (p = 0.05). A statisti-
cal power of 1.0 was reached between all comparisons.
Comparison of means between both CGs showed no sig-
nificant difference between groups, a significant differ-
ence between time points (p = 0.05) and no significant
interaction between groups. Comparison of means
between both TGs showed a significant difference
between groups and time points (p = 0.05) but no signif-
icant interaction between groups.
ANOVA-1 comparison of mean TSAA levels between 0 hr
and each time point showed significant (p ≤ 0.05)
increases in all TGs and CGs. In CG-A2.5, the mean 0 hr
TSAA level of 1.71 mg/L increased significantly at each
time point, except the 0.5 hr to a maximum level of 2.22
mg/L in 4 hr. In TG-A2.5 the mean 0 hr TSAA level of 2.01
mg/L increased significantly at each time point except the
0.5 hr to a maximum level of 4.23 mg/L in 4 hr (Figure 1).
In CG-A5, the mean 0 hr TSAA level of 1.87 mg/L
increased significantly at each time point, except the 0.5
hr to a maximum level of 2.28 mg/L in 4 hr. In TG-A5 the
mean 0 hr TSAA level of 1.99 mg/L increased significantly
at each time point except the 0.5 hr to a maximum level of
4.52 mg/L in 4 hr (Figure 2).
Individual amino acid levels
The relative percent AUC for each of the eighteen AAs ana-
lyzed in CG-A2.5 and TG-A2.5 at 0 hr and 4 hr is shown
in Figure 3 and 4. The sum of the average area percent for
each AA equals 100% of the AUC. ANOVA-1 statistical
analysis between CG-A2.5 and TG-A2.5 at 0 hr showed
arginine, aspartic acid, cysteine, methionine, phenyla-
lanine, serine, tryptophan and valine (8 of 18) to be sig-
nificantly (p ≤ 0.05) different. No significant differences
were found between alanine, glutamine, glycine, histi-
dine, isoleucine, leucine, lysine, proline, threonine and
tyrosine. At 0 hr statistically significant differences
between CG-A5 and TG-A5 include arginine, aspartic acid,
glycine, histidine, isoleucine, lysine, methionine, proline,
serine and threonine (10 of 18). No significant differences
were found between alanine, glutamine, cysteine, leucine,
phenylalanine, tryptophan, tyrosine and valine. At 4 hr
statistically significant differences between CG-A2.5 and
TG-A2.5 include alanine, arginine, aspartic acid, cysteine,
glutamine, isoleucine, leucine, lysine, phenylalanine, pro-
line, threonine, tryptophan, tyrosine and valine (14 of
18). No significant differences were found in glycine, his-
tidine, methionine and serine. At 4 hr statistically signifi-
cant differences between CG-A5 and TG-A5 include
alanine, arginine, aspartic acid, cysteine, glutamine, gly-
cine, histidine, isoleucine, leucine, lysine, phenylalanine,Journal of the International Society of Sports Nutrition 2008, 5:10 http://www.jissn.com/content/5/1/10
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proline, threonine, tryptophan, tyrosine and valine (16 of
18). Methionine and serine were the only two amino
acids that were not significantly different.
Some AAs, including lysine, phenylalanine, tyrosine and
the branched chain amino acids (BCAAs) isoleucine, leu-
cine and valine, showed significantly greater fluctuation
between 0 hr to 4 hr in each CG compared to each TG.
CG-A2.5 showed a 78% decrease in the AUC of phenyla-
lanine and a 69% decrease in tyrosine, compared to a 22%
decrease and a 52% decrease, respectively, in TG-A2.5.
These decreases are compensated for by a 170% increase
in the AUC of lysine and a 232% increase in the AUC of
BCAAs in CG-A2.5, compared to a 100% increase and a
144% increase respectively TG-A2.5.
CG-A5 showed a 74% decrease in the AUC of phenyla-
lanine and a 66% decrease in tyrosine between 0 hr and 4
hr, compared to an 18% decrease and a 72% decrease,
respectively, in TG-A5. These decreases are compensated
for by a 120% increase in the AUC of lysine and a 259%
increase in the AUC of BCAAs in CG-A5 compared to an
85% increase and a 163% increase respectively TG-A5.
Nitrogen excretion
The average amount of N2 excreted in 24 hours was deter-
mined as urea for each TG and CG. ANOVA-2 showed that
the mean N2 excretion decreased significantly (p < 0.05)
in each TG compared to each corresponding CG. The
mean difference between both TGs and between both
CGs, as well as the interaction between both TGs and
between both CGs is not significant (Figure 5). A statisti-
cal power of 1 was reached between each TG and corre-
sponding CG. In TG-A2.5 and TG-A5 the average amount
of N2 excreted over 24 hours was 7.18 g and 7.1 g respec-
tively. In CG-A2.5 and CG-A5 the average amount of N2
excreted over 24 hours was 10.02 g and 11.05 g respec-
tively.
C-reactive protein
CRP was measured at 0 hr, 2 hr and 4 hr in each CG and
TG (Figure 6). ANOVA-2 comparison of means between
each CG and corresponding TG showed significant differ-
ences (p = 0.05) between time points and dose groups. A
statistical power of 1.0 was reached between each TG and
corresponding CG. No significant differences were found
when comparing the means of both CGs and both TGs.
The interaction between time points was also not signifi-
Individual Amino Acid AUC 0 hr Figure 3
Individual Amino Acid AUC 0 hr. Average percent area 
under the curve (AUC) differences between eighteen amino 
acids in CG-A2.5 (n = 21) and TG-A2.5 (n = 21) at 0 hr. Val-
ues are means ± SEM. * Indicates significant difference (p = 
0.05).
CG-A2.5 and TG-A2.5 Average Total Serum Amino Acids  (TSAA) Figure 1
CG-A2.5 and TG-A2.5 Average Total Serum Amino 
Acids (TSAA). Average levels of TSAA in Control Group 
(CG) A2.5 (n = 21) and Test Group (TG) A2.5 (n = 21). Val-
ues are means ± SEM. * Indicates significant change from 
baseline (p = 0.05). t Indicates significant difference between 
groups (p = 0.05).
CG-A5 and TG-A5 Average Total Serum Amino Acids  (TSAA) Figure 2
CG-A5 and TG-A5 Average Total Serum Amino 
Acids (TSAA). Average levels of TSAA in Control Group 
(CG) A5 (n = 21) and Test Group (TG) A5 (n = 21). Values 
are means ± SEM. * Indicates significant change from baseline 
(p = 0.05). t Indicates significant difference between groups 
(p = 0.05).Journal of the International Society of Sports Nutrition 2008, 5:10 http://www.jissn.com/content/5/1/10
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cant. No significant changes were found between 0 hr and
2 hr in either CG or TG. Significant (p ≤ 0.05) reductions
were found between 0 hr and 4 hr in each TG and not in
either CG. TG-A2.5 showed a reduction of 10.12% and
TG-A5 showed a reduction of 11.4%.
Discussion
The purpose of this study was to determine if Aminogen®,
a patented blend of digestive proteases from Aspergillus
niger and Aspergillus oryzae, would significantly affect the
amount of processed WPC metabolized in-vivo and
whether any effect would be sufficient to significantly
alter N2 balance and CRP levels. Comparing levels of
TSAA after ingestion, with and without Aminogen®, would
indicate if the proteolytic enzymes were effective in
increasing the amount of WPC metabolized.
The results show that postprandial TSAA levels were sig-
nificantly increased over controls from a 50 g dose of Ala-
cen 131 WPC containing either 2.5 or 5 g of Aminogen®
(Figures 1 and 2). This indicates that protease supplemen-
tation increased the absorption rate amount of the WPC
and is further supported by significant (2.2 and 3.5 times)
increases in the AUC in each TG relative to each CG. After
base line subtraction, no significant differences were
found between the AUC of each TG indicating that the
WPC absorption rate may close to maximum in TG-A2.5.
Further studies may confirm this by increasing the
number of TGs consuming various amounts of Amino-
gen®. The significantly higher levels of AAs in the TGs may
be related to significant increases in N2 retention and sig-
nificant decreases in CRP levels. TSAA levels in each TG
appeared to be sustained much longer in this study than
in earlier studies using a 30 g dose of WP isolate from milk
[1,2]. Peak postprandial plasma AA levels in those studies
were reported at approximately 1.5 hours and returning to
baseline values in approximately five hours. In this study,
A. CRP Levels in Control Group (CG) and Test Group (TG)  A2.5 Figure 6
A. CRP Levels in Control Group (CG) and Test 
Group (TG) A2.5. Average C-reactive protein (CRP) levels 
between CG-A2.5 and TG-A2.5 (n = 16). Values are means ± 
SEM. * Indicates significant difference (p = 0.05). B. CRP Lev-
els in Control Group (CG) and Test Group (TG) A5. Aver-
age C-reactive protein (CRP) levels between CG-A5 and 
TG-A5 (n = 16). Values are means ± SEM. * Indicates signifi-
cant difference (p = 0.05).
Individual Amino Acid AUC 4 hr Figure 4
Individual Amino Acid AUC 4 hr. Average percent area 
under the curve (AUC) differences between eighteen amino 
acids in CG-A2.5 (n = 21) and TG-A2.5 (n = 21) at 4 hr. Val-
ues are means ± SEM. * Indicates significant difference (p = 
0.05).
Total Nitrogen Excretion Figure 5
Total Nitrogen Excretion. Average 24 hour nitrogen 
excretion between Test Group (TG) A2.5 and Control 
Group (CG) A2.5 (n = 18). Average 24 hour nitrogen excre-
tion between TG-A5 and CG-A5 (n = 19). Values are means 
± SEM. * Indicates significant difference between correspond-
ing TG and CG (p = 0.05).Journal of the International Society of Sports Nutrition 2008, 5:10 http://www.jissn.com/content/5/1/10
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postprandial TSAA levels appear to have been still increas-
ing or peaked at four hours. Several factors may be respon-
sible for these differences, including the amount ingested
and over-processing.
The amount of WPC ingested may have saturated endog-
enous proteolytic enzymes, the rate-limiting step in the
digestion process. Decreased digestion from over-process-
ing can also slow digestive enzymes [5]. These factors
impede the absorption rate, which may limit the amount
of protein absorbed before reaching the ceacum. The addi-
tion of Aminogen® provided more proteolytic enzymes
thereby possibly increasing the absorption rate during the
same time period. Whether the addition of Aminogen®
affected one or more of these factors in this study is
unknown at this time but the over-all effect appears to be
a significant increase in the WPC absorption rate.
Results of IAA indicate that Aminogen® supplementation
may contribute to decreased whole body protein metabo-
lism. Decreased flux of IAA levels such as phenylalanine
and valine have been reported to be indicators of
decreased whole body protein metabolism and decreased
N2 excretion [1,14]. Fluctuations in tyrosine, phenyla-
lanine and BCAAs were compared using average percent
AUC. In this model the sum of all eighteen AAs at each
time point is equal to 100% of the AUC. Fluctuation in
the level of one amino acid must be compensated for by
an opposing relative fluctuation in one or more other
amino acids. The results show significantly less fluctua-
tion in these essential AAs between 0 hr to 4 hr in each TG
than in each CG, indicating decreased whole body protein
metabolism. These results, together with significant
increases in TSAAs, indicate that Aminogen® supplementa-
tion may contribute to optimal conditions for protein
synthesis and growth. This is consistent with a significant
decrease in average N2 excretion in the TGs of 7.3 g com-
pared to an average of 10.18 g in the CGs (equivalent to
approximately 44.6 g and 63.6 g of protein, respectively).
These differences offer further support that whole body
protein metabolism was decreased in each TG. Further
studies can verify this by subtracting baseline urinary N2
levels and measuring N2 excretion each hour during the
course of the study and several hours post study. These
results also suggest increased protein utilization; however
blood urea nitrogen (BUN) and insulin levels should have
been monitored to be more certain.
With respect to CRP levels, these results show no signifi-
cant effect in each CG. However, CRP levels decreased sig-
nificantly between 0 hr and 4 hr in each TG, A2.5 (p =
0.0038) and A5 (p = 0.0026). This may be related to the
differences in the amount of WPC digested and absorbed
between each CG and TG. Previous studies have shown
that peptides produced from in-vitro, enzymatic hydroly-
sis of WP are bioactive in reducing CRP [11]. Supplement-
ing with Aminogen®  may contribute to significantly
reducing CRP levels by producing bioactive peptides in-
vivo.
Conclusion
Factors such as high protein intake and over-processing
may contribute to a decreased absorption rate of WPC and
lower than expected blood levels of individual amino
acids. This may also cause digestion to take longer and be
less complete than expected. The results of this study indi-
cate that supplementing 50 g of WPC with 50 mg/g or 100
mg/g Aminogen®, a blend of food grade proteases from
Aspergillus niger and Aspergillus oryzae patented for use as a
digestive aid, significantly increased the absorption rate of
WPC over controls. This is reflected in statistically signifi-
cant (p ≤ 0.05) increases in postprandial AUC, TSAA lev-
els, ISAA levels and N2 balance. Significant decreases in
CRP levels and fluxes in AA levels (possibly contributing
to a decrease in whole body protein metabolism) are also
reported. Further, these results indicate the need for fur-
ther research in the area of enzyme supplementation for a
more complete digestion of protein and perhaps other
processed foods.
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